Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens
Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens
Genome-wide loss-of-function screens using the CRISPR/Cas9 system allow the efficient discovery of cancer cell vulnerabilities. While several studies have focused on correcting for DNA cleavage toxicity biases associated with copy number alterations, the effects of sgRNAs co-targeting multiple genomic loci in CRISPR screens have not been discussed.